Oramed Issues Letter to Shareholders

– Recruiting and Dosing Patients Across Growing Number of U.S. Sites in Phase 3 Oral Insulin Trial   – Clinical Advancements in NASH & Leptin   – Discussions with Potential Partners Under Way   – To view a video message from the CEO, click here   NEW YORK, Jan. 27, 2021 /PRNewswire/ — Oramed Pharmaceuticals […]

Join our mailing list

Skip to content